Tokyo, Japan

Miho Ikenaga


 

Average Co-Inventor Count = 10.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Miho Ikenaga: Innovator in Medicinal Chemistry

Introduction

Miho Ikenaga is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative compounds and their applications in medicine. With a total of three patents to his name, Ikenaga has established himself as a key figure in the development of new therapeutic agents.

Latest Patents

Ikenaga's latest patents include a compound known as 2-[5-(imidazol-1-ylmethyl)pyridin-3-yl]benzimidazole derivative. This compound is notable for its potential use in medicaments. Another significant patent is for a 2-(3-pyridinyl)-1H-benzimidazole derivative compound, which also includes a medicament containing the same. These innovations highlight his focus on creating compounds that can be utilized in medical treatments.

Career Highlights

Throughout his career, Miho Ikenaga has worked with notable organizations such as Nihon Medi-Physics Company, Limited and the National Hospital Organization. His experience in these institutions has allowed him to refine his expertise in the field of medicinal chemistry and contribute to various research projects.

Collaborations

Ikenaga has collaborated with several professionals in his field, including Akihiro Izawa and Yuki Okumura. These partnerships have facilitated the exchange of ideas and advancements in their shared research interests.

Conclusion

Miho Ikenaga's work in medicinal chemistry and his innovative patents demonstrate his commitment to advancing medical science. His contributions are paving the way for new therapeutic options and enhancing the understanding of medicinal compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…